Gian Paolo Rossi Selected Research

Gian Paolo Rossi Research Topics

Disease

85	Hyperaldosteronism (Conn Syndrome) 03/2024 - 07/2002
79	Hypertension (High Blood Pressure) 03/2024 - 02/2002
60	Adenoma (Adenomas) 05/2024 - 02/2006
13	Neoplasms (Cancer) 01/2022 - 03/2006
13	Coronary Artery Disease (Coronary Atherosclerosis) 10/2015 - 03/2003
12	Cardiovascular Diseases (Cardiovascular Disease) 05/2023 - 02/2002
11	Hypokalemia 03/2024 - 04/2008
10	Essential Hypertension 12/2023 - 07/2008
10	Hyperplasia 09/2019 - 04/2004
9	Atherosclerosis 11/2017 - 11/2003
8	Heart Failure 11/2022 - 01/2003
7	Pheochromocytoma 11/2023 - 03/2006
7	Hypertrophy 06/2016 - 02/2002
6	Fibrosis (Cirrhosis) 03/2016 - 02/2003
5	Stroke (Strokes) 01/2022 - 01/2003
5	Body Weight (Weight, Body) 10/2008 - 02/2002
4	Chronic Renal Insufficiency 12/2023 - 01/2016
4	Inflammation (Inflammations) 12/2023 - 03/2016
4	Adrenocortical Carcinoma 05/2023 - 03/2005
4	Overweight 01/2018 - 03/2003
3	Addison Disease (Addison's Disease) 11/2023 - 09/2022
3	COVID-19 10/2023 - 01/2020
3	Renovascular Hypertension (Goldblatt Syndrome) 11/2022 - 05/2002
3	Familial Hyperaldosteronism 01/2022 - 09/2016
3	Gitelman Syndrome 08/2018 - 02/2014
3	Pre-Eclampsia (Preeclampsia) 01/2018 - 02/2013
3	Vascular Remodeling 01/2018 - 01/2003
3	Hypotension (Low Blood Pressure) 11/2015 - 04/2004
2	Chronic Disease (Chronic Diseases) 12/2023 - 01/2016
2	Pulmonary Embolism 10/2023 - 01/2022
2	Paraganglioma (Paragangliomas) 10/2022 - 01/2022
2	Cushing Syndrome 10/2022 - 01/2022
2	Adrenal Insufficiency (Adrenal Gland Hypofunction) 09/2022 - 01/2022
2	Myocardial Infarction 01/2022 - 05/2006
2	Left Ventricular Dysfunction 01/2022 - 01/2007
2	Hypovolemia 01/2021 - 12/2019
2	Atrial Fibrillation 11/2019 - 01/2018
2	Hyperparathyroidism 01/2019 - 08/2012
2	Channelopathies 12/2018 - 09/2014
2	Airway Obstruction (Choking) 01/2018 - 10/2016
2	Hyperhomocysteinemia 01/2018 - 04/2005
2	Obstructive Sleep Apnea 01/2018 - 11/2016

Drug/Important Bio-Agent (IBA)

83	AldosteroneIBA 05/2024 - 07/2002
26	ReninIBA 01/2023 - 05/2002
15	Angiotensin IIIBA 05/2022 - 02/2002
9	Endothelins (Endothelin)IBA 01/2023 - 01/2003
9	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2022 - 03/2006
8	Mineralocorticoid Receptor AntagonistsIBA 03/2024 - 10/2013
8	Proteins (Proteins, Gene)FDA Link 12/2023 - 04/2004
8	Antihypertensive Agents (Antihypertensives)IBA 11/2022 - 05/2008
7	SodiumIBA 12/2023 - 08/2007
7	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 05/2023 - 12/2007
6	Messenger RNA (mRNA)IBA 12/2023 - 03/2006
6	Hormones (Hormone)IBA 12/2023 - 01/2018
6	PotassiumIBA 01/2021 - 09/2014
5	MineralocorticoidsIBA 01/2021 - 09/2006
5	AngiotensinsIBA 01/2021 - 05/2002
5	HomocysteineIBA 12/2008 - 01/2005
5	MDL 100240IBA 07/2006 - 02/2002
4	AcidsIBA 05/2023 - 04/2014
4	Adrenocorticotropic Hormone (ACTH)FDA Link 09/2022 - 02/2006
4	Type 1 Angiotensin ReceptorIBA 05/2022 - 02/2014
4	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 05/2022 - 07/2002
4	Peptides (Polypeptides)IBA 01/2021 - 05/2002
4	Captopril (Capoten)FDA LinkGeneric 01/2019 - 12/2006
4	Endothelin-1 (Endothelin 1)IBA 01/2018 - 02/2002
4	Ramipril (Altace)FDA LinkGeneric 07/2006 - 02/2002
4	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 09/2004 - 03/2003
3	CanrenoneIBA 12/2023 - 01/2019
3	SteroidsIBA 12/2023 - 10/2022
3	Cosyntropin (Cortrosyn)FDA LinkGeneric 03/2020 - 01/2017
3	AutoantibodiesIBA 10/2019 - 02/2013
3	AntioxidantsIBA 11/2015 - 01/2013
3	EnzymesIBA 11/2015 - 11/2003
3	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 10/2015 - 01/2012
3	oxidized low density lipoproteinIBA 06/2014 - 10/2003
3	LDL Lipoproteins (beta Lipoproteins)IBA 09/2013 - 11/2003
3	Irbesartan FDA LinkGeneric 10/2008 - 07/2002
3	AdiponectinIBA 10/2008 - 06/2006
3	CollagenIBA 02/2003 - 07/2002
2	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 03/2024 - 12/2014
2	SaltsIBA 12/2023 - 01/2019
2	MicroRNAs (MicroRNA)IBA 01/2023 - 10/2022
2	GlucocorticoidsIBA 09/2022 - 01/2022
2	Dexamethasone (Maxidex)FDA LinkGeneric 09/2022 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 11/2015
2	NormetanephrineIBA 01/2022 - 10/2021
2	CytokinesIBA 01/2022 - 11/2017
2	Androstenedione (4 Androstene 3,17 dione)IBA 10/2021 - 01/2017
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2020 - 04/2004
2	olmesartanIBA 01/2020 - 01/2019
2	Oxygen (Dioxygen)IBA 01/2019 - 10/2016
2	MacrolidesIBA 01/2018 - 12/2017
2	Metoclopramide (Reglan)FDA LinkGeneric 01/2018 - 11/2016
2	AntigensIBA 11/2017 - 03/2010

Therapy/Procedure

38	Adrenalectomy 12/2023 - 03/2002
14	Therapeutics 09/2022 - 09/2006
5	Continuous Positive Airway Pressure 01/2018 - 06/2014
3	Nephrectomy 06/2006 - 03/2002
2	Denervation 01/2022 - 07/2013